<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Strobbia P</submitter><funding>NIBIB NIH HHS</funding><pagination>4090-4102</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7977455</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(9)</volume><pubmed_abstract>For the majority of cancer patients, surgery is the primary method of treatment. In these cases, accurately removing the entire tumor without harming surrounding tissue is critical; however, due to the lack of intraoperative imaging techniques, surgeons rely on visual and physical inspection to identify tumors. Surface-enhanced Raman scattering (SERS) is emerging as a non-invasive optical alternative for intraoperative tumor identification, with high accuracy and stability. However, Raman detection requires dark rooms to work, which is not consistent with surgical settings. &lt;b>Methods:&lt;/b> Herein, we used SERS nanoprobes combined with shifted-excitation Raman difference spectroscopy (SERDS) detection, to accurately detect tumors in xenograft murine model. &lt;b>Results:&lt;/b> We demonstrate for</pubmed_abstract><journal>Theranostics</journal><pubmed_title>Accurate &lt;i>in vivo&lt;/i> tumor detection using plasmonic-enhanced shifted-excitation Raman difference spectroscopy (SERDS).</pubmed_title><pmcid>PMC7977455</pmcid><funding_grant_id>R01 EB028078</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Fales AM</pubmed_authors><pubmed_authors>Pfefer TJ</pubmed_authors><pubmed_authors>Sumpf B</pubmed_authors><pubmed_authors>Cupil-Garcia V</pubmed_authors><pubmed_authors>Crawford BM</pubmed_authors><pubmed_authors>Strobbia P</pubmed_authors><pubmed_authors>Maiwald M</pubmed_authors><pubmed_authors>Vo-Dinh T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Accurate &lt;i>in vivo&lt;/i> tumor detection using plasmonic-enhanced shifted-excitation Raman difference spectroscopy (SERDS).</name><description>For the majority of cancer patients, surgery is the primary method of treatment. In these cases, accurately removing the entire tumor without harming surrounding tissue is critical; however, due to the lack of intraoperative imaging techniques, surgeons rely on visual and physical inspection to identify tumors. Surface-enhanced Raman scattering (SERS) is emerging as a non-invasive optical alternative for intraoperative tumor identification, with high accuracy and stability. However, Raman detection requires dark rooms to work, which is not consistent with surgical settings. &lt;b>Methods:&lt;/b> Herein, we used SERS nanoprobes combined with shifted-excitation Raman difference spectroscopy (SERDS) detection, to accurately detect tumors in xenograft murine model. &lt;b>Results:&lt;/b> We demonstrate for</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-25T18:38:41.406Z</modification><creation>2025-04-06T07:41:18.14Z</creation></dates><accession>S-EPMC7977455</accession><cross_references><pubmed>33754050</pubmed><doi>10.7150/thno.53101</doi></cross_references></HashMap>